Introduction
Methods
Eligibility criteria
Search strategy and guideline selection
Data extraction and rating of the guidelines
Analysis
Results
Guideline identification
Title | Scope and key questions | National society and/or authors | Year | Methodological approach |
---|---|---|---|---|
Uveal Melanoma UK National Guidelines | The use and effectiveness of new technologies such as cytogenetics/genetic analysis for prognostication The appropriate pathway for the surveillance of patients following treatment for primary uveal melanoma The use and effectiveness of new technologies in the treatment of hepatic recurrence The use of systemic treatments | UK Melanoma Study Group, Uveal Melanoma Guideline Development Group Nathan et al. (2015) | 2015 | Evidence- and consensus-based |
The American Brachytherapy Society consensus guidelines for plaque brachytherapy of uveal melanoma and retinoblastoma | To present the American Brachytherapy Society guidelines for plaque brachytherapy of choroidal melanoma and retinoblastoma | American Brachytherapy Society—Ophthalmic Oncology Task Force (Simpson et al. 2014) | 2014 | Evidence- and survey-based, consensus-based |
Management of uveal melanoma: a consensus-based provincial clinical practice guideline | How should patients with uveal melanoma be staged at baseline? How should uveal melanoma be managed? What follow-up testing is required for uveal melanoma patients? | Weis et al. (2016) | 2016 | Evidence- and consensus-based |
NCCN Clinical Practice Guidelines in Oncology: Uveal Melanoma | Explain differences in recommendations for molecular testing in uveal versus cutaneous melanoma Identify the most commonly used primary treatments for uveal melanoma and name the patient- and case-specific factors that would influence selection among these treatment options Describe the recommended imaging follow-up for patients with prior localized uveal melanoma, and explain why it differs from that for cutaneous melanoma | National Comprehensive Cancer Network (NCCN) Panel for Melanoma (Oncology 2018) | 2018 | Evidence- and consensus-based |
Intraocular (Uveal) Melanoma Treatment | Treatment of intraocular melanoma. It is intended as a resource to inform and assist clinicians who care for cancer patients | National Cancer Institute (2019) | 2019 | Evidence-based, peer-reviewed |